Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
4507 On Other Exchanges
4507 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Isao Teshirogi Ph.D.

Chief Executive Officer, President and Representative Director,Shionogi & Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 40 board members in 3 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Isao Teshirogi, Ph.D., has been the President and Chief Executive Officer of Shionogi & Co. Ltd. since April 1, 2008. Dr. Teshirogi served as the Executive General Manager of Pharmaceutical Research & Development Division at Shionogi & Co. Ltd., since 2006 and also served as its General Manager of Pharmaceutical Research & Development Division since 1999, General Manager of Secretary Office from January 1998 to October 2002, General Manager of Corporate Planning ...

Read Full Background

Corporate Headquarters*

1-8, Doshomachi 3-chome
Osaka, -- 541-0045


Phone: 81 6 6202 2161
Fax: 81 6 6229 9596

Board Members Memberships*

Chief Executive Officer, President and Representative Director


The University of Tokyo
The University of Tokyo

Other Affiliations*

Annual Compensation*

Total Annual Compensation¥105,000,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation¥105,000,000
Total Short Term Compensation¥105,000,000
Total Calculated Compensation¥122,000,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4507:JP ¥5,596.00 JPY +7.00


Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHIONOGI & CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at